HERON THERAPEUTICS, INC. /DE/ — Director's Dealing 2019

Dec 23, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HERON THERAPEUTICS, INC. /DE/ (HRTX)
CIK: 0000818033
Period of Report: 2019-12-19

Reporting Person: HOFFMAN ROBERT (CFO & SVP, Finance)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-19	Employee Stock Option (Right to Buy)	$25.02	A	100000	Acquired	2029-12-19	Common Stock (100000)	Direct

Footnotes

F1: The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant.